Elevated Expression of RGS2 May Underlie Reduced Olfaction in COVID-19 Patients

Anosmia is common in COVID-19 patients, lasting for weeks or months following recovery. The biological mechanism underlying olfactory deficiency in COVID-19 does not involve direct damage to nasal olfactory neurons, which do not express the proteins required for SARS-CoV-2 infection. A recent study...

Descripción completa

Detalles Bibliográficos
Autores principales: Avnat, Eden, Shapira, Guy, Gurwitz, David, Shomron, Noam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504192/
https://www.ncbi.nlm.nih.gov/pubmed/36143181
http://dx.doi.org/10.3390/jpm12091396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504192/
https://www.ncbi.nlm.nih.gov/pubmed/36143181
http://dx.doi.org/10.3390/jpm12091396

Ejemplares similares